# A Study of BYL719 in Adult Patients With Advanced Solid Malignancies

> **NCT01387321** · PHASE1 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 33 (actual)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** BYL719

## Key facts

- **NCT ID:** NCT01387321
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09-22
- **Primary completion:** 2015-11-25
- **Final completion:** 2015-11-25
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2020-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01387321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01387321, "A Study of BYL719 in Adult Patients With Advanced Solid Malignancies". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01387321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*